Literature DB >> 34109407

Rapid spread of critical priority carbapenemase-producing pathogens in companion animals: a One Health challenge for a post-pandemic world.

Fábio P Sellera1,2, Luciano C B A Da Silva2, Nilton Lincopan3,4.   

Abstract

The COVID-19 pandemic has increased relationships and interactions between human and companion animals, supported by widespread social distancing and isolation measures. Additionally, the COVID-19 pandemic has led to an exponential growth in antibiotic and biocide use worldwide, possibly inducing further pressure, contributing to the selection of antibiotic-resistant bacteria, including WHO critical priority pathogens. While data from global surveillance studies reveal a linear trend of increasing carbapenem resistance among Gram-negative pathogens from companion animals, the acquisition of carbapenemase-producing Enterobacterales through direct contact with colonized hosts and contaminated veterinary hospital environments has been documented. This article highlights the rapid spread of WHO critical priority carbapenemase-producing pathogens in companion animals, which is a One Health challenge for a post-pandemic world.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 34109407     DOI: 10.1093/jac/dkab169

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Characterization of 2 Klebsiella pneumoniae carbapenemase-producing Enterobacterales isolated from canine rectal swabs.

Authors:  Stephen D Cole; Shelley C Rankin
Journal:  J Vet Diagn Invest       Date:  2021-12-21       Impact factor: 1.279

2.  A Survey of Current Activities and Technologies Used to Detect Carbapenem Resistance in Bacteria Isolated from Companion Animals at Veterinary Diagnostic Laboratories-United States, 2020.

Authors:  Michelle A Waltenburg; Alicia Shugart; John Dustin Loy; Deepanker Tewari; Shuping Zhang; Stephen D Cole; Maroya Spalding Walters; Megin Nichols
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 11.677

3.  Massive Spread of OXA-48 Carbapenemase-Producing Enterobacteriaceae in the Environment of a Swiss Companion Animal Clinic.

Authors:  Kira Schmitt; Michael Biggel; Roger Stephan; Barbara Willi
Journal:  Antibiotics (Basel)       Date:  2022-02-08

4.  WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil.

Authors:  Bruna Fuga; Fábio P Sellera; Louise Cerdeira; Fernanda Esposito; Brenda Cardoso; Herrison Fontana; Quézia Moura; Adriana Cardenas-Arias; Elder Sano; Rosineide M Ribas; Albalúcia C Carvalho; Maria Cristina B Tognim; Marcia Maria C de Morais; Ana Judith P G Quaresma; Ângela Patrícia Santana; Joice N Reis; Marcelo Pilonetto; Eliana Carolina Vespero; Raquel R Bonelli; Aloysio M F Cerqueira; Thaís C M Sincero; Nilton Lincopan
Journal:  Microbiol Spectr       Date:  2022-03-02

Review 5.  The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens.

Authors:  Carole Ayoub Moubareck; Dalal Hammoudi Halat
Journal:  Front Cell Infect Microbiol       Date:  2022-03-17       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.